Does 18F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?-Reference-Cited by-同舟云学术

Does 18F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?

Published:2014-08-25 Issue:8 Volume:9 Page:e105679
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cho Yuri,Lee Dong Hyeon,Lee Yun Bin,Lee Minjong,Yoo Jeong-ju,Choi Won-mook,Cho Young Youn,Paeng Jin Chul,Kang Keon Wook,Chung June-Key,Yu Su Jong,Lee Jeong-Hoon,Yoon Jung-Hwan,Lee Hyo-Suk,Kim Yoon Jun

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Screening for hepatocellular carcinoma;GH Haydon;Eur J Gastroenterol Hepatol,1996

2. Rising incidence of hepatocellular carcinoma in the United States;HB El-Serag;N Engl J Med,1999

3. Increase in primary liver cancer in the UK, 1979–94;SD Taylor-Robinson;Lancet,1997

4. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years;T Nakashima;Cancer,1983

5. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases;K Yuki;Cancer,1990

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidentally found parotid gland lesion in 18F-FDG PET/CT for staging evaluation of patients with hepatocellular carcinoma: remote possibility of metastatic tumor or second primary salivary gland malignancy;BMC Surgery;2024-04-24

2. INASL Consensus on Management of HCC: Navigating an Evolving Field;Journal of Clinical and Experimental Hepatology;2024-01

3. Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer;Indian Journal of Cancer;2024-01

4. Detection of Primary Hepatocellular Carcinoma on18F-Fluorodeoxyglucose Positron Emission Tomography-computed Tomography;Euroasian journal of hepato-gastroenterology;2023-12-22

5. Primäre und sekundäre Lebertumore – aus Sicht der Nuklearmedizin;Angewandte Nuklearmedizin;2023-12